Showing 7801-7810 of 20409 results for "".
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
https://reachmd.com/programs/project-oncology/precision-strikes-in-nuclear-medicine-to-treat-prostate-cancer/24495/What can we expect about novel approaches and combination therapies? Tune in.ADHD in Older Adults: Key Diagnostic and Treatment Strategies
https://reachmd.com/programs/neurofrontiers/adhd-in-older-adults-key-diagnostic-and-treatment-strategies/18152/Tune in to find out how you can diagnose and treat older adults with ADHD.MS Management: Strategies for Ensuring Equitable Access to Teleneurology
https://reachmd.com/programs/frontlines-multiple-sclerosis/ms-management-strategies-for-ensuring-equitable-access-to-teleneurology/32669/Teleneurology can help provide multidisciplinary care to patients with multiple sclerosis, but key strategies are needed to ensure equitable use.COPD-OSA Overlap: Diagnostic and Management Gaps
https://reachmd.com/programs/clinicians-roundtable/copd-osa-overlap-diagnosis-management-gaps/54221/Adenoma Detection Rate: A Prediction of Colorectal Cancer
https://reachmd.com/programs/gi-insights/adenoma-detection-rate-a-prediction-of-colorectal-cancer/14232/What do we need to know about adenoma detection rate—and can it help predict our patients’ risk of developing colorectal cancer?RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
https://reachmd.com/programs/neurofrontiers/raise-subgroup-analysis-zilucoplan/51013/Once-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
https://reachmd.com/clinical-practice/dermatology/once-daily-oral-zasocitinib-demonstrates-rapid-and-reproducible-skin-clearance-with-a-consistent-safety-profile-in-moderate-to-severe-plaque-psoriasis-results-from-two-randomized-phase-3-trials-latitude-pso-3001-and-3002/56617/Review Phase 3 trial data (LATITUDE-PsO-3001 and 3002) on once-daily oral zasocitinib in moderate-to-severe plaque psoriasis.Bridging Gaps with Blood-Based CRC Screening
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/bridging-gaps-blood-crc-screening/49172/Blood-based testing has the potential to expand access to colorectal cancer (CRC) screening for average-risk adults who decline colonoscopy or stool-based options. In this discussion with Ryan Quigley, Dr. Aasma Shaukat unpacks recent findings on test performance, clinical use cases, and possible reApplying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
https://reachmd.com/programs/neurofrontiers/applying-cbt-for-psychosis-in-schizophrenia-care-strategies-for-expanding-access/36647/Despite decades of evidence supporting cognitive behavioral therapy (CBT) for psychosis, most patients with schizophrenia in the U.S. never receive it due to systemic barriers like provider shortages and fragmented transitions after hospitalization. To address these gaps, Dr. David Kimhy joins Dr. CThe LDL-C-Lowering Landscape: Navigating Current and Future Therapeutic Options
https://reachmd.com/clinical-practice/cardiology/the-ldl-c-lowering-landscape-navigating-current-and-future-therapeutic-options/48693/Explore why LDL-C remains a central target in ASCVD care and discover how emerging lipid-lowering therapies are reshaping the treatment landscape.